Marinus Pharmaceuticals develops and sells drugs for people with rare genetic epilepsies. ZTALMY is an oral suspension they offer, which can treat seizures associated with cyclin-dependent kinase-like 5 deficiency disorder. They're also developing ganaxolone for treating other genetic epilepsy disorders, depressive disorders, and Lennox-Gestaut Syndrome.